What is realist research, when should we consider it, how and why?

被引：0
|
作者：
Mitchell, Sarah [1 ,2 ]
Ahmed, Zahra [1 ]
Slowther, Anne-Marie [2 ,3 ]
Coad, Jane
Dale, Jeremy [2 ]
机构：
[1] Univ Sheffield, Oncol & Metab, Sheffield S10 2SJ, S Yorkshire, England
[2] Univ Warwick, Warwick Med Sch, Coventry, W Midlands, England
[3] Univ Nottingham, Sch Hlth Sci, Nottingham, England
来源：
ARCHIVES OF DISEASE IN CHILDHOOD-EDUCATION AND PRACTICE EDITION | 2022年 / 107卷 / 06期
基金：
美国国家卫生研究院;
关键词：
health services research; data collection; palliative care;
D O I：
10.1136/archdischild-2021-322017
中图分类号：
R72 [儿科学];
学科分类号：
100202 ;
摘要：
[No abstract available]
引用
收藏
页码：448 / 450
页数：3
相关论文
共 50 条
  • [41] Why Are We Doing This? And What Should We Be Doing?
    Warren, Linda P.
    Axtell, Rich
    JOURNAL AMERICAN WATER WORKS ASSOCIATION, 2016, 108 (10): : 14 - +
  • [42] Quality of life in cardiovascular disease What is it and why and how should we measure it?
    Ski, Chantal F.
    Thompson, David R.
    EUROPEAN JOURNAL OF CARDIOVASCULAR NURSING, 2010, 9 (04) : 201 - 202
  • [43] Should we Try to Alleviate Immunosenescence and Inflammaging - Why, How and to What Extent?
    Witkowski, Jacek M.
    Bryl, Ewa
    Fulop, Tamas
    CURRENT PHARMACEUTICAL DESIGN, 2019, 25 (39) : 4154 - 4162
  • [44] Why and When Should We Conduct Collaborative International Oncology Nursing Research?
    Hinds, Pamela S.
    Bedinger, Alicia
    CANCER NURSING, 2011, 34 (04) : 253 - 254
  • [45] Peer assessment and professional behaviours: what should we be assessing, how, and why?
    Tai, Joanna
    Adachi, Chie
    MEDICAL EDUCATION, 2017, 51 (04) : 346 - 347
  • [46] Should we consider the hippocampus when optimizing the IMRT of NPC?
    Mnejja, W.
    Daoud, H.
    Farhat, L.
    Fourati, N.
    Siala, W.
    Daoud, J.
    RADIOTHERAPY AND ONCOLOGY, 2019, 132 : 35 - 36
  • [47] Organ donation: when should we consider intestinal donation
    Fischer-Froehlich, Carl-Ludwig
    Koenigsrainer, Alfred
    Schaffer, Randolph
    Schaub, Franz
    Pratschke, Johann
    Pascher, Andreas
    Steurer, Wolfgang
    Nadalin, Silvio
    TRANSPLANT INTERNATIONAL, 2012, 25 (12) : 1229 - 1240
  • [48] SHOULD WE CONSIDER FRAILTY WHEN TREATING ATRIAL FIBRILLATION?
    Wilkinson, C.
    Todd, O.
    Clegg, A.
    Gale, C. P.
    Hall, M.
    AGE AND AGEING, 2019, 48
  • [49] Why and when should we cluster randomize?
    Giraudeau, Bruno
    Weijer, Charles
    Eldridge, Sandra M.
    Hemming, Karla
    Taljaard, Monica
    JOURNAL OF EPIDEMIOLOGY AND POPULATION HEALTH, 2024, 72 (01):
  • [50] HOW DO WE MEASURE WHAT WE GET WHEN WE BUY RESEARCH
    MANSFIELD, E
    SCIENTIST, 1991, 5 (16): : 11 - &
12345